Cargando…
RE: Long-Term Outcomes of Sentinel Lymph Node Biopsy for Ductal Carcinoma in Situ
Autores principales: | Meurs, Claudia J C, Menke-Pluijmers, Marian B E, Siesling, Sabine, Westenend, Pieter J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771425/ https://www.ncbi.nlm.nih.gov/pubmed/33417657 http://dx.doi.org/10.1093/jncics/pkaa079 |
Ejemplares similares
-
Surgeons’ preferences for using sentinel lymph node biopsy in patients with ductal carcinoma in situ
por: Meurs, Claudia J. C., et al.
Publicado: (2022) -
Predicting Lymph Node Metastases in Patients with Biopsy-Proven Ductal Carcinoma In Situ of the Breast: Development and Validation of the DCIS-met Model
por: Meurs, Claudia J. C., et al.
Publicado: (2022) -
Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis Ductal Carcinoma In Situ
por: Meurs, Claudia J. C., et al.
Publicado: (2023) -
A prediction model for underestimation of invasive breast
cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies
and 589 invasive cancers
por: Meurs, Claudia J. C., et al.
Publicado: (2018) -
Ductal Carcinoma In Situ and Sentinel Lymph Node Biopsy
por: Son, Bok Kyoung, et al.
Publicado: (2011)